Phase II trial of triglycidylurazol (TGU) in advanced malignant melanoma. 1987

S Gundersen, and R Abele, and F Cavalli, and M Clavel, and P Dodion, and G Renard, and M van Glabbeke

UI MeSH Term Description Entries
D008545 Melanoma A malignant neoplasm derived from cells that are capable of forming melanin, which may occur in the skin of any part of the body, in the eye, or, rarely, in the mucous membranes of the genitalia, anus, oral cavity, or other sites. It occurs mostly in adults and may originate de novo or from a pigmented nevus or malignant lentigo. Melanomas frequently metastasize widely, and the regional lymph nodes, liver, lungs, and brain are likely to be involved. The incidence of malignant skin melanomas is rising rapidly in all parts of the world. (Stedman, 25th ed; from Rook et al., Textbook of Dermatology, 4th ed, p2445) Malignant Melanoma,Malignant Melanomas,Melanoma, Malignant,Melanomas,Melanomas, Malignant
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D014230 Triazoles Heterocyclic compounds containing a five-membered ring with two carbon atoms and three nitrogen atoms with the molecular formula C2H3N3. Triazole

Related Publications

S Gundersen, and R Abele, and F Cavalli, and M Clavel, and P Dodion, and G Renard, and M van Glabbeke
June 1987, European journal of cancer & clinical oncology,
S Gundersen, and R Abele, and F Cavalli, and M Clavel, and P Dodion, and G Renard, and M van Glabbeke
March 1985, European journal of cancer & clinical oncology,
S Gundersen, and R Abele, and F Cavalli, and M Clavel, and P Dodion, and G Renard, and M van Glabbeke
February 1987, Cancer treatment reports,
S Gundersen, and R Abele, and F Cavalli, and M Clavel, and P Dodion, and G Renard, and M van Glabbeke
February 1983, European journal of cancer & clinical oncology,
S Gundersen, and R Abele, and F Cavalli, and M Clavel, and P Dodion, and G Renard, and M van Glabbeke
November 1987, European journal of cancer & clinical oncology,
S Gundersen, and R Abele, and F Cavalli, and M Clavel, and P Dodion, and G Renard, and M van Glabbeke
June 2002, American journal of clinical oncology,
S Gundersen, and R Abele, and F Cavalli, and M Clavel, and P Dodion, and G Renard, and M van Glabbeke
November 1986, European journal of cancer & clinical oncology,
S Gundersen, and R Abele, and F Cavalli, and M Clavel, and P Dodion, and G Renard, and M van Glabbeke
July 1987, European journal of cancer & clinical oncology,
S Gundersen, and R Abele, and F Cavalli, and M Clavel, and P Dodion, and G Renard, and M van Glabbeke
January 1985, Cancer treatment reports,
S Gundersen, and R Abele, and F Cavalli, and M Clavel, and P Dodion, and G Renard, and M van Glabbeke
January 1987, Journal of cancer research and clinical oncology,
Copied contents to your clipboard!